Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

Epignostix

Epignostix is an AI-driven diagnostic tumor classifier founded in 2022.

Overview Structured Data Issues Contributors Activity

epignostix.com

Is a

Organization

Company

Company attributes

Industry

Biotechnology

Software as a service (SaaS)

Health technology

B2X

B2B

Number of Employees (Ranges)

1 – 10

Investors

LBBW VC

Founded Date

2022

Total Funding Amount (USD)

9,400,000

Latest Funding Round Date

July 2, 2024

Latest Funding Type

Seed

Country

Germany

Headquarters

Heidelberg

Other attributes

Latest Funding Round Amount (USD)

4,700,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Epignostix

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API